Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? (Q53230969)

12 May 2018

title

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? (English)

1 reference

12 May 2018

author name string

Thome J

1

1 reference

12 May 2018

Gewirtz JC

2

1 reference

12 May 2018

Sakai N

3

1 reference

12 May 2018

Zachariou V

4

1 reference

12 May 2018

Retz-Junginger P

5

1 reference

12 May 2018

Retz W

6

1 reference

12 May 2018

Duman RS

7

1 reference

12 May 2018

Rösler M

8

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

12 May 2018

published in

Neuroscience Letters

1 reference

12 May 2018

volume

274

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

37-40

1 reference

12 May 2018

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Association between bleomycin hydrolase and Alzheimer's disease in caucasians.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Nucleotide sequence and structure of the human apolipoprotein E gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

History of Depression and Other Psychiatric Illness as Risk Factors for Alzheimer Disease in a Twin Sample

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900662-X

7 January 2021

10.1016/S0304-3940(99)00662-X

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018